{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:02:50Z","timestamp":1789401770952,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-025-01936-8","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T15:26:24Z","timestamp":1761146784000},"page":"5407-5425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Frailty elements, direct oral anticoagulants and mortality risk in atrial fibrillation patients aged\u2009\u2265\u200980 or\u2009\u2265\u200990\u00a0years from the nationwide Italian START registry: a propensity score matching analysis"],"prefix":"10.1007","volume":"48","author":[{"given":"Danilo","family":"Menichelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Antonucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Baratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Armentaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gazzaniga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Moscucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gualtiero","family":"Palareti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristo","family":"Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"START2 Register Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"2","key":"1936_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.55838","volume":"6","author":"S Khurshid","year":"2023","unstructured":"Khurshid S, Ashburner JM, Ellinor PT, McManus DD, Atlas SJ, Singer DE, et al. Prevalence and incidence of atrial fibrillation among older primary care patients. JAMA Netw Open. 2023;6(2):e2255838. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.55838.","journal-title":"JAMA Netw Open"},{"key":"1936_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2021-001624","author":"B Morseth","year":"2021","unstructured":"Morseth B, Geelhoed B, Linneberg A, Johansson L, Kuulasmaa K, Salomaa V, et al. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM consortium. Open Heart. 2021. https:\/\/doi.org\/10.1136\/openhrt-2021-001624.","journal-title":"Open Heart"},{"issue":"1","key":"1936_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jjcc.2020.07.022","volume":"77","author":"M Koshiyama","year":"2021","unstructured":"Koshiyama M, Tamaki K, Ohsawa M. Age-specific incidence rates of atrial fibrillation and risk factors for the future development of atrial fibrillation in the Japanese general population. J Cardiol. 2021;77(1):88\u201392. https:\/\/doi.org\/10.1016\/j.jjcc.2020.07.022.","journal-title":"J Cardiol"},{"issue":"5","key":"1936_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/STROKEAHA.114.004903","volume":"45","author":"L Melgaard","year":"2014","unstructured":"Melgaard L, Rasmussen LH, Skjoth F, Lip GY, Larsen TB. Age dependence of risk factors for stroke and death in young patients with atrial fibrillation: a nationwide study. Stroke; a journal of cerebral circulation. 2014;45(5):1331\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.114.004903.","journal-title":"Stroke; a journal of cerebral circulation"},{"issue":"8","key":"1936_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamacardio.2021.1232","volume":"6","author":"H Abdel-Qadir","year":"2021","unstructured":"Abdel-Qadir H, Singh SM, Pang A, Austin PC, Jackevicius CA, Tu K, et al. Evaluation of the risk of stroke without anticoagulation therapy in men and women with atrial fibrillation aged 66 to 74 years without other CHA2DS2-VASc factors. JAMA cardiology. 2021;6(8):918\u201325. https:\/\/doi.org\/10.1001\/jamacardio.2021.1232.","journal-title":"JAMA cardiology"},{"issue":"FI1","key":"1936_CR6","doi-asserted-by":"publisher","first-page":"f11","DOI":"10.1093\/ehjcvp\/pvab002","volume":"7","author":"D Menichelli","year":"2021","unstructured":"Menichelli D, Del Sole F, Di Rocco A, Farcomeni A, Vestri A, Violi F, et al. Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients. Eur Heart J. 2021;7(FI1):f11\u20139. https:\/\/doi.org\/10.1093\/ehjcvp\/pvab002.","journal-title":"Eur Heart J"},{"issue":"36","key":"1936_CR7","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176.","journal-title":"Eur Heart J"},{"key":"1936_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003432","author":"ET Kato","year":"2016","unstructured":"Kato ET, Giugliano RP, Ruff CT, Koretsune Y, Yamashita T, Kiss RG, et al. Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.116.003432.","journal-title":"J Am Heart Assoc"},{"issue":"15","key":"1936_CR9","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s11606-022-07410-x","volume":"37","author":"W Wang","year":"2022","unstructured":"Wang W, Saczynski JS, Lessard D, Goldberg RJ, Parish D, Helm R, et al. Presence of geriatric conditions is prognostic of major bleeding in older patients with atrial fibrillation: a cohort study. J Gen Intern Med. 2022;37(15):3893\u20139. https:\/\/doi.org\/10.1007\/s11606-022-07410-x.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"1936_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100129","volume":"7","author":"S Nishimura","year":"2023","unstructured":"Nishimura S, Kumamaru H, Shoji S, Nakatani E, Yamamoto H, Ichihara N, et al. Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: the Shizuoka study. Res Pract Thromb Haemost. 2023;7(3):100129. https:\/\/doi.org\/10.1016\/j.rpth.2023.100129.","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"1936_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2459\/JCM.0000000000000986","volume":"21","author":"V De Simone","year":"2020","unstructured":"De Simone V, Mugnolo A, Zanotto G, Morando G. Direct oral anticoagulants for patients aged over 80 years in nonvalvular atrial fibrillation: the impact of frailty. J Cardiovasc Med. 2020;21(8):562\u20139. https:\/\/doi.org\/10.2459\/JCM.0000000000000986.","journal-title":"J Cardiovasc Med"},{"key":"1936_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030469","author":"M Proietti","year":"2022","unstructured":"Proietti M, Camera M, Gallieni M, Gianturco L, Gidaro A, Piemontese C, et al. Use and prescription of direct oral anticoagulants in older and frail patients with atrial fibrillation: a multidisciplinary consensus document. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12030469.","journal-title":"J Pers Med"},{"issue":"9921","key":"1936_CR13","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0.","journal-title":"Lancet"},{"issue":"1","key":"1936_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.14744\/AnatolJCardiol.2017.8256","volume":"19","author":"I Cavallari","year":"2018","unstructured":"Cavallari I, Patti G. Efficacy and safety of oral anticoagulation in elderly patients with atrial fibrillation. Anatol J Cardiol. 2018;19(1):67\u201371. https:\/\/doi.org\/10.14744\/AnatolJCardiol.2017.8256.","journal-title":"Anatol J Cardiol"},{"issue":"11","key":"1936_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","volume":"56","author":"R Marinigh","year":"2010","unstructured":"Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients: implications for thromboprophylaxis. J Am Coll Cardiol. 2010;56(11):827\u201337. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.028.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1936_CR16","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1111\/jgs.17884","volume":"70","author":"SL Harrison","year":"2022","unstructured":"Harrison SL, Buckley BJR, Ritchie LA, Proietti R, Underhill P, Lane DA, et al. Oral anticoagulants and outcomes in adults >\/=80 years with atrial fibrillation: a global federated health network analysis. J Am Geriatr Soc. 2022;70(8):2386\u201392. https:\/\/doi.org\/10.1111\/jgs.17884.","journal-title":"J Am Geriatr Soc"},{"key":"1936_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105602","volume":"128","author":"V Arcoraci","year":"2025","unstructured":"Arcoraci V, Rottura M, Gianguzzo VM, Pallio G, Imbalzano E, Nobili A, et al. Atrial fibrillation management in older hospitalized patients: evidence of a poor oral anticoagulants prescriptive attitude from the Italian REPOSI registry. Arch Gerontol Geriatr. 2025;128:105602. https:\/\/doi.org\/10.1016\/j.archger.2024.105602.","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"1936_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.123.066485","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten LPT, van Doorn S, van de Ven PM, Kohlen BTG, Nierman MC, Koek HL, et al. Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149(4):279\u201389. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066485.","journal-title":"Circulation"},{"issue":"5","key":"1936_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124719","volume":"10","author":"E Antonucci","year":"2015","unstructured":"Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, et al. The Italian START-Register on anticoagulation with focus on atrial fibrillation. PLoS ONE. 2015;10(5):e0124719. https:\/\/doi.org\/10.1371\/journal.pone.0124719.","journal-title":"PLoS ONE"},{"issue":"36","key":"1936_CR20","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","volume":"45","author":"L Mazzolai","year":"2024","unstructured":"Mazzolai L, Teixido-Tura G, Lanzi S, Boc V, Bossone E, Brodmann M, et al. 2024 ESC guidelines for the management of peripheral arterial and aortic diseases. Eur Heart J. 2024;45(36):3538\u2013700. https:\/\/doi.org\/10.1093\/eurheartj\/ehae179.","journal-title":"Eur Heart J"},{"issue":"5","key":"1936_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"key":"1936_CR22","doi-asserted-by":"publisher","unstructured":"Ternavasio-de la Vega HG, Castano-Romero F, Ragozzino S, Sanchez Gonzalez R, Vaquero-Herrero MP, Siller-Ruiz M, et al. The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia. Epidemiol Infect. 2018;146(16):2122\u201330. https:\/\/doi.org\/10.1017\/S0950268818002480.","DOI":"10.1017\/S0950268818002480"},{"issue":"1","key":"1936_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cjca.2021.09.021","volume":"38","author":"M Orlandi","year":"2022","unstructured":"Orlandi M, Dover DC, Sandhu RK, Hawkins NM, Kaul P, McAlister FA. The introduction of direct oral anticoagulants has not resolved treatment gaps for frail patients with nonvalvular atrial fibrillation. Can J Cardiol. 2022;38(1):77\u201384. https:\/\/doi.org\/10.1016\/j.cjca.2021.09.021.","journal-title":"Can J Cardiol"},{"issue":"2","key":"1936_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40119-013-0019-y","volume":"2","author":"KH Ng","year":"2013","unstructured":"Ng KH, Hart RG, Eikelboom JW. Anticoagulation in patients aged >\/=75 years with atrial fibrillation: role of novel oral anticoagulants. Cardiol Ther. 2013;2(2):135\u201349. https:\/\/doi.org\/10.1007\/s40119-013-0019-y.","journal-title":"Cardiol Ther"},{"key":"1936_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12081339","author":"MC Vedovati","year":"2022","unstructured":"Vedovati MC, Agnelli G. Direct oral anticoagulants in old and frail patients with atrial fibrillation: the advantages of an anticoagulation service. J Pers Med. 2022. https:\/\/doi.org\/10.3390\/jpm12081339.","journal-title":"J Pers Med"},{"key":"1936_CR26","doi-asserted-by":"publisher","unstructured":"Caldeira D, Alves da Silva P, Pinto FJ. Clinical outcomes of anticoagulated patients with atrial fibrillation after falls or head injury: insights from RE-LY. Stroke; a journal of cerebral circulation. 2023;54(6):1656\u20139. https:\/\/doi.org\/10.1161\/STROKEAHA.122.041628.","DOI":"10.1161\/STROKEAHA.122.041628"},{"issue":"11","key":"1936_CR27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacc.2016.06.034","volume":"68","author":"J Steffel","year":"2016","unstructured":"Steffel J, Giugliano RP, Braunwald E, Murphy SA, Mercuri M, Choi Y, et al. Edoxaban versus warfarin in atrial fibrillation patients at risk of falling: ENGAGE AF-TIMI 48 analysis. J Am Coll Cardiol. 2016;68(11):1169\u201378. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.034.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"1936_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40266-021-00870-6","volume":"38","author":"W Wei","year":"2021","unstructured":"Wei W, Rasu RS, Hernandez-Munoz JJ, Flores RJ, Rianon NJ, Hernandez-Vizcarrondo GA, et al. Impact of fall risk and direct oral anticoagulant treatment on quality-adjusted life-years in older adults with atrial fibrillation: a Markov decision analysis. Drugs Aging. 2021;38(8):713\u201323. https:\/\/doi.org\/10.1007\/s40266-021-00870-6.","journal-title":"Drugs Aging"},{"issue":"1","key":"1936_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/STROKEAHA.114.007199","volume":"46","author":"GY Lip","year":"2015","unstructured":"Lip GY, Clementy N, Pericart L, Banerjee A, Fauchier L. Stroke and major bleeding risk in elderly patients aged >\/=75 years with atrial fibrillation: the Loire Valley atrial fibrillation project. Stroke; a journal of cerebral circulation. 2015;46(1):143\u201350. https:\/\/doi.org\/10.1161\/STROKEAHA.114.007199.","journal-title":"Stroke; a journal of cerebral circulation"},{"key":"1936_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j510","volume":"356","author":"PB Nielsen","year":"2017","unstructured":"Nielsen PB, Skjoth F, Sogaard M, Kjaeldgaard JN, Lip GY, Larsen TB. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2017;356:j510. https:\/\/doi.org\/10.1136\/bmj.j510.","journal-title":"BMJ"},{"key":"1936_CR31","doi-asserted-by":"publisher","unstructured":"Brunetti E, Presta R, Okoye C, Filippini C, Raspo S, Bruno G, et al. Predictors and outcomes of oral anticoagulant deprescribing in geriatric inpatients with atrial fibrillation: a retrospective multicenter cohort study. J Am Med Dir Assoc. 2024;25(3):545\u201351 e4. https:\/\/doi.org\/10.1016\/j.jamda.2024.01.011.","DOI":"10.1016\/j.jamda.2024.01.011"},{"issue":"4","key":"1936_CR32","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s41999-023-00811-z","volume":"14","author":"A Mitchell","year":"2023","unstructured":"Mitchell A, Elmasry Y, van Poelgeest E, Welsh TJ. Anticoagulant use in older persons at risk for falls: therapeutic dilemmas-a clinical review. Eur Geriatr Med. 2023;14(4):683\u201396. https:\/\/doi.org\/10.1007\/s41999-023-00811-z.","journal-title":"Eur Geriatr Med"},{"issue":"5","key":"1936_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216831","volume":"14","author":"D Poli","year":"2019","unstructured":"Poli D, Antonucci E, Ageno W, Bertu L, Migliaccio L, Martinese L, et al. Oral anticoagulation in very elderly patients with atrial fibrillation: results from the prospective multicenter START2-REGISTER study. PLoS ONE. 2019;14(5):e0216831. https:\/\/doi.org\/10.1371\/journal.pone.0216831.","journal-title":"PLoS ONE"},{"issue":"1","key":"1936_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6\u201314. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02007.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1936_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2165\/00002512-200320060-00004","volume":"20","author":"BR Williams","year":"2003","unstructured":"Williams BR, Kim J. Cardiovascular drug therapy in the elderly: theoretical and practical considerations. Drugs Aging. 2003;20(6):445\u201363. https:\/\/doi.org\/10.2165\/00002512-200320060-00004.","journal-title":"Drugs Aging"},{"issue":"4","key":"1936_CR36","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/geronj\/27.4.438","volume":"27","author":"LP Novak","year":"1972","unstructured":"Novak LP. Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. J Gerontol. 1972;27(4):438\u201343. https:\/\/doi.org\/10.1093\/geronj\/27.4.438.","journal-title":"J Gerontol"},{"issue":"3","key":"1936_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3724\/SP.J.1263.2011.00184","volume":"8","author":"HC Lee","year":"2011","unstructured":"Lee HC, Tl Huang K, Shen WK. Use of antiarrhythmic drugs in elderly patients. J Geriatr Cardiol. 2011;8(3):184\u201394. https:\/\/doi.org\/10.3724\/SP.J.1263.2011.00184.","journal-title":"J Geriatr Cardiol"},{"key":"1936_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2024.04.009","volume":"238","author":"J Stuby","year":"2024","unstructured":"Stuby J, Haschke M, Tritschler T, Aujesky D. Oral anticoagulant therapy in older adults. Thromb Res. 2024;238:1\u201310. https:\/\/doi.org\/10.1016\/j.thromres.2024.04.009.","journal-title":"Thromb Res"},{"issue":"7","key":"1936_CR39","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.mayocp.2018.10.022","volume":"94","author":"D Pastori","year":"2019","unstructured":"Pastori D, Pignatelli P, Menichelli D, Violi F, Lip GYH. Integrated care management of patients with atrial fibrillation and risk of cardiovascular events: the ABC (atrial fibrillation better care) pathway in the ATHERO-AF study cohort. Mayo Clin Proc. 2019;94(7):1261\u20137. https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.022.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"1936_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCULATIONAHA.117.031658","volume":"138","author":"TF Chao","year":"2018","unstructured":"Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, et al. Oral anticoagulation in very elderly patients with atrial fibrillation: a nationwide cohort study. Circulation. 2018;138(1):37\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031658.","journal-title":"Circulation"},{"issue":"8","key":"1936_CR41","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1080\/13696998.2019.1606001","volume":"22","author":"JB Briere","year":"2019","unstructured":"Briere JB, Bowrin K, Millier A, Toumi M, Wojciechowski P, Taieb V. Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation. J Med Econ. 2019;22(8):760\u20135. https:\/\/doi.org\/10.1080\/13696998.2019.1606001.","journal-title":"J Med Econ"},{"key":"1936_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.675200","volume":"8","author":"Y Wu","year":"2021","unstructured":"Wu Y, Zhang C, Gu ZC. Cost-effectiveness analysis of direct oral anticoagulants vs. vitamin K antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world setting. Front Cardiovasc Med. 2021;8:675200. https:\/\/doi.org\/10.3389\/fcvm.2021.675200.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"1936_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","volume":"69","author":"FR Rosendaal","year":"1993","unstructured":"Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236\u20139.","journal-title":"Thromb Haemost"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-025-01936-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-025-01936-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:04:46Z","timestamp":1789398286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-025-01936-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1936"],"URL":"https:\/\/doi.org\/10.1007\/s11357-025-01936-8","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}